Although pro-stromal and pro-malignant, CSPG4 was not yet considered as a pathogenic factor or biomarker in pancreatic cancer; a stroma-rich aggressive malignancy [3], [21]. The gene discussed is CSPG4; the disease is pancreatic neoplasm.